Karuna Therapeutics Inc.
KRTX | NASDAQ
$329.83
+$0.09 (+0.03%)
At close: Mar 15, 2024, 04:00 PM ET
Market Data
Market Cap $12.6B
Enterprise Value $11.35B
Beta 1.15
Average Volume N/A
Shares Outstanding (Diluted) 37.78M
Shares Change YoY 9.81%
Institutional Ownership N/A
Exchange N/A
ISIN N/A
Price Performance
Price Change 1M N/A
Price Change 3M N/A
Price Change 6M N/A
Price Change YTD N/A
Price Change 1Y N/A
Price Change 3Y N/A
Price Change 5Y N/A
1M CAGR (ann.) 4.8%
1Y CAGR (ann.) 74.2%
5Y CAGR (ann.) N/A
All-Time CAGR 80.9%
Valuation
PE Ratio -28.96
Forward PE 26.83
PEG Ratio 1.02
Forward PEG -0.01
PS Ratio 19,264.95
Forward PS 8.90
PB Ratio 10.05
P/FCF Ratio -32.41
P/Adj. FCF Ratio -27.19
P/OCF Ratio -31.59
EV/Sales 17,359.56
EV/EBIT -24.32
EV/EBITDA -22.97
EV/FCF -29.21
Earnings Yield -3.5%
FCF Yield -3.1%
Adj. FCF Yield -3.7%
Financial Health
Net Cash $1.25B
Total Debt $16.69M
Cash & Short-Term Investments $1.26B
Total Assets $1.34B
Current Ratio 19.31
Quick Ratio 18.82
Debt / Equity Ratio 0.01
Debt / EBITDA -0.03
Debt / FCF -0.04
OCF / Debt -23.12
Interest Coverage 0.00
Altman Z-Score 91.14
Piotroski F-Score 1
Margins & Profitability
Gross Profit Margin -160.1%
Operating Profit Margin -75654.0%
EBITDA Margin -75393.9%
Net Profit Margin -66311.9%
FCF Margin -59439.8%
Adj. FCF Margin -70846.3%
SBC / Revenue 11406.6%
SBC Impact (per share) -19.2%
Returns
Return on Assets -32.5%
Return on Equity -36.4%
Return on Invested Capital -38.9%
Return on Capital Employed -39.0%
Return on Tangible Assets -32.5%
Historical Growth (CAGR)
Revenue CAGR 3Y -112.9%
Revenue CAGR 5Y 12.4%
Revenue CAGR 10Y N/A
EPS CAGR 3Y -39.1%
EPS CAGR 5Y 76.1%
EPS CAGR 10Y N/A
FCF CAGR 3Y -59.2%
FCF CAGR 5Y -53.1%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 25
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y N/A
Earnings Date May 1, 2024
EPS Estimate (next Q) -$3.06
EPS Growth Est (next Q) 9.3%
Revenue Est (next Q) $340K
Revenue Growth Est (next Q) -48.0%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $257.50
Price Target Upside -21.9%
Cash Flow
Operating Cash Flow $-385.82M
Free Cash Flow $-388.74M
Adj. Free Cash Flow $-463.34M
FCF Per Share -$10.52
OCF Per Share -$10.44
OCF/S Ratio -58993.7%
Income Statement
Revenue $654K
Gross Profit $-1.05M
Operating Income $-494.78M
EBITDA $-494.33M
Net Income $-422.19M
EPS (Diluted) -$11.39
Revenue / Employee N/A
Profit / Employee N/A
Employees N/A
Add to Watchlist
Select watchlists to add or remove KRTX